Skip to content

Retrospective Analysis of Natural History of Patients with Pearson Syndrome

Retrospective Analysis of Natural History of Patients with Pearson Syndrome

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00021754
Enrollment
25
Registered
2020-06-05
Start date
2020-06-03
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

D64

Interventions

Group 1: 1) Blood, bone marrow smears have previously been submitted for the reference diagnosis. 2) The blood and bone marrow smears were evaluated by microscope. 3) The clinical and laboratory at d

Sponsors

Universitätsklinikum Freiburg, Kinder- und Jugendmedizin, Klinik IV, Pädiatrische Hämatologie/Onkologie
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Individuals of any age with a confirmed diagnosis of Pearson syndrome are included. Pearson syndrome required the presence of anaemia at diagnosis and typical bone marrow finding with vacuolization of marrow precursors and/or ring sideroblasts. 2. Genetic confirmation of the diagnosis by detection of a large scale mtDNA deletion is necessary.

Exclusion criteria

Exclusion criteria: 1. Absence of a genetic report indicating a large scale mtDNA deletion 2. No informed consent from parents

Design outcomes

Primary

MeasureTime frame
• To analyze hematological values and bone marrow findings at diagnosis in patients with Pearson syndrome. • To demonstrate the natural history of patients

Secondary

MeasureTime frame
• To determine incidences and time-points of appearances of varied non-hematological complications • To analyze the incidence and the time-point of hematological recovery • To determine genetic and clinical predictors of the clinical course of Pearson Syndrome

Countries

Germany

Contacts

Public ContactAyami Yoshimi-Nöllke

Kinder- und Jugendklinik, Klinik Pädiatrische Hämatologie und Onkologie

ayami.yoshimi@uniklinik-freiburg.de49-761-270-43000

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026